The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

EACR member awarded Sjöberg Prize for decisive discoveries about cell growth

February 14, 2020

The Royal Swedish Academy of Sciences has decided to award the Sjöberg Prize 2020 of one million US dollars to Michael N. Hall (Biozentrum, University of Basel) who is an EACR member, and David M. Sabatini (Massachusetts Institute of Technology (MIT) and Whitehead Institute). The two researchers have radically changed ideas about cell growth, an important factor in the development of cancer. In doing so, they laid the foundation for new forms of cancer treatment.

Above you can watch a video created by the Royal Swedish Academy of Sciences all about their discovery of mTOR and its role in the control of cell metabolism and growth.

This is the fourth time the Sjöberg Prize has been awarded. The Royal Swedish Academy of Sciences selects the Laureates and the Prize is financed by the Sjöberg Foundation. It was established after Bengt Sjöberg, a Swedish businessman who had cancer himself, donated two billion Swedish krona to promote scientific research that primarily focuses on cancer, health and the environment.

Tags: EACR Membersnews summaryvideo

Related Posts

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

October 8, 2026

Click above to watch On 07 October 2026, the EACR hosted a webinar in collaboration with QIAGEN, one of our valued EACR Industry Partners. γδ T...

VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms

VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms

October 1, 2026

Click above to watch On 29 September 2026, the EACR hosted a webinar in collaboration with Roche, one of our valued EACR Industry Partners. Antibody-Drug Conjugates...

From T-cell repertoires to biological insight: exploring antigen specificity in cancer immunology

From T-cell repertoires to biological insight: exploring antigen specificity in cancer immunology

October 9, 2026

Advances in next-generation sequencing (NGS) have transformed cancer immunology research. Today, researchers can profile T-cell receptor (TCR) repertoires in unprecedented detail, revealing how immune cell populations...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report
Career

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report

October 12, 2026
VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
News

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

October 8, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR